John Jurkiewicz Email & Phone Number

Greater St. Louis

Greater St. Louis

St Louis, Missouri, United States

• Provided COVID-19 disease state awareness and education within a complex and rapidly changing environment.
• Launched a small, molecular IV antiviral for SARS-CoV-2 known as the first FDA approved COVID-19 medication.
• Offered KOL identification and development, including a OLP lead.
• Delivered National Treatment Guideline and Clinical Pathway education, development, and pull-through.
• Collaborated with field and non-field-based personnel to provide individual customer support and meet needs as the pandemic evolves; earned a rank of 8/51 for Q2, and 13/51 year to date.

St. Louis, MO

• Senior Therapeutic Specialist (2016 – Present) | Therapeutic Specialist (2011 – 2015)
• Accomplished the Key Contributor award in 2015 and 2017 – a stock award granted to less than 10% of Gilead employees.
• Won five out of six phases of the 2017 and 2018 NRx sales contests, in addition to capturing the Drive for Results award in 2016 as one of three top-performers recognized as representative of the quarter, outranking.
• Assumed responsibilities for rare disease state selling—primarily Pulmonary Arterial Hypertension—leveraging relationship building capabilities to achieve and exceed sales objectives.
• Led the HIV Pre-Exposure Prevention (PrEP) selling strategy to accelerate HIV prevention care management and drive new business development.
• Demonstrated sales leadership throughout tenure that resulted in participation in several strategic regional and national initiatives and teams.

St. Louis, MO

• Championed the new product launch of Tekturna, Valturna, and Exforge at Novartis Pharmaceuticals, earning a leadership plaque in honor of success as Lead of the Tekturna launch.
• Marketed and sold a portfolio of anti-hypertension medications including Diovan, Tekturna, Valturna, and Exforge, fostering lasting relationships with endocrinologists, cardiologists, nephrologists, and primary care.
• Hand-selected by management as the Team Lead working alongside direct and indirect counterparts, in addition to securing placement on the Regional Focus Group in 2008.
• Bolstered sales volume year-over-year (YOY) between 2008 and 2009 through targeted prospecting and relationship-building founded in a total office call approach.
• Developed an internal competition based on performance tracking relative to a super-target focus list, which yielded significant, profitable growth in major accounts.

St. Louis, MO

• Accomplished District Territory Manager of the Year Award as Senior Territory Manager at Organon Pharmaceuticals, showcasing excellence in consultative selling.
• Cultivated relationships with pain specialists, neurologists, oncologists, orthopedic surgeons, anesthesiologists, psychiatrists, and physiatrists for the sale of Nuva Ring, Avinza, Zemuron, Arixtra, Remeron, and.
• Expanded Avinza sales between 2003 and 2004; retained momentum to achieve position among top performers regionally regarding market share growth of the same product in Q2 2005.
• Surpassed national sales growth of Remeron SolTab in 2003, accomplishing ranking among top performers regionally and nationally.
• Served as an active member of the Regional Advisory Board, leveraging sales expertise to drive high-impact sales and marketing strategies that bolstered top-line revenue.

St. Louis, MO

• Drove sales of key pharmaceutical products such as Avelox across St. Louis territory, consistently exceeding sales goals, which led to increased company performance in regional pharmaceutical market.
• Recognized and promoted to Management Training Program as a result of successful tenure while also providing mentorship and training for all new hires and existing district representatives.
• Developed diverse background in pharmaceutical corporate landscape that provided a deeply-rooted network of physicians in Urology, Cardiology, and Primary Care positions throughout St. Louis..

Bachelor Of Science (Bs), Fitness & Wellness

Master Of Business Administration (Mba)